- £193.50m
- £183.35m
- £51.12m
Brief: Tristel Confirms Submission Of Additional Information To FDA For Tristel OPH
Director/PDMR Shareholding
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Brief: Tristel H1 Pretax Profit GBP 3.657 Million
Unaudited Interim Results
Exercise of Share Options and Total Voting Rights
Director Option Grant
Confirmation of Interim Results
Brief: Tristel Expects To Hit Three-Year Target Of 10% - 15% Revenue Growth By June 30 2025
AGM Statement and Notice of Interim Results
Notice of AGM & Posting of Annual Report &Accounts
Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights
Exercise of Share Options and Total Voting Rights
Brief: Tristel Plc FY Adjusted EPS 15.34p
Final Results
Notice of Preliminary Results